Lantern Pharma Confirms Panna Sharma Continues to Serve as President and CEO; Alerts Investors to False Third-Party Report

Go back to Lantern Pharma Confirms Panna Sharma Continues to Serve as President and CEO; Alerts Investors to False Third-Party Report
(NASDAQ: LTRN) Delayed: 3.88 +0.09 (2.37%)
Previous Close $3.79    52 Week High
Open $3.84    52 Week Low
Day High $4.10    P/E N/A 
Day Low $3.77    EPS
Volume 104,334